Dupixent
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Package | Class |
|---|---|---|---|---|
| 200 MG/1.14 ML | Pen | $1,777.89 / mL† | — | Brand |
| 200 MG/1.14 ML | Syringe | $1,771.37 / mL† | — | Brand |
| 300 MG/2 ML | Pen | $1,009.29 / mL† | — | Brand |
| 300 MG/2 ML | Syringe | $1,010.30 / mL† | — | Brand |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Brand list prices fall after confidential rebates. † Package size not curated yet — priced per single unit/mL, not per full pen, inhaler, or vial.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $2,351,310,109 gross for Dupixent across 616,804 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$2,491,772,008 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS